A Greener Tomorrow: How Pack8's Project Aranyam is Making an Impact
In an era where sustainability is a necessity, Pack8 is leading the charge with innovative eco-friendly packaging solutions. Praveen Shinde, Founder of Pack8 is committed to eliminating single-use plastic waste, the company has transitioned to paper-based materials, already removing over 3,600+ tons of single-use plastic waste from the environment.
One of its most ambitious initiatives, Project Aranyam, is not just about sustainability, it's about creating a long-lasting impact on the planet. With a goal to plant 1 million trees by 2030, this project directly offsets carbon emissions, fosters biodiversity, and provides employment opportunities for local communities.
Key Achievements of Project Aranyam
As per Akshay Mhole, who leads the sustainability initiatives at Pack8, The Project Aryanam has planted more than 14,169 trees, sequestering 283,380 kg of CO2 upon maturity. He says that the initiative is not just about planting trees but ensuring their long-term survival. Each tree is nurtured for up to five years, increasing its chances of thriving and maximizing its environmental impact.
Beyond its environmental benefits, the project has also provided employment opportunities for local communities, making sustainability an economic driver.
Purplle, one of India's leading omnichannel beauty destinations quoted 'At Purplle, we believe that every small step towards sustainability counts. Partnering with Pack8 and adopting HexCush Honeycomb paper rolls has helped us eliminate plastic waste while actively contributing to reforestation through the Aryanam Project. It's a powerful reminder that responsible packaging can drive real environmental change.'
How Project Aranyam Works
In Project Aranyam, whenever Pack8 processes a significant amount of paper at their factory, they give back to nature by planting a tree, integrating sustainability directly into the company's business model. Trees play a crucial role in carbon sequestration, with a single mature tree absorbing approximately 20 kg of CO2 per year. Beyond just planting, Pack8 focuses on creating Microforests, Agro Forests, and Miyawaki Forests, enhancing biodiversity while strengthening ecosystems. Unlike many tree-planting initiatives, Pack8 ensures long-term maintenance for every tree, making the project truly impactful.
Pack8's Shift to Sustainable Materials
Beyond tree planting, Pack8 is revolutionizing the packaging industry by replacing plastic with sustainable alternatives. The company has already eliminated 3,600+ tons of single use plastic waste by transitioning to paper-based packaging. Additionally, Pack8 is moving away from virgin kraft paper, embracing 100% recycled paper, a move that significantly reduces environmental impact while promoting responsible sourcing. In FY 24-25, they have processed 466 tons of recycled paper and for FY 25-26 they are projecting to process 3000 tons of recycled paper.
Aligning with Global Sustainability Goals
Project Aranyam aligns with six key United Nations Sustainable Development Goals (SDGs). By absorbing CO2 and mitigating climate change, it contributes to Climate Action (SDG 13). Its reforestation efforts support biodiversity and restore ecosystems, addressing Life on Land (SDG 15). Urban tree plantations improve air quality and reduce heat islands, promoting Sustainable Cities and Communities (SDG 11). By prioritizing sustainable packaging solutions, Pack8 fosters Responsible Consumption and Production (SDG 12). The initiative also creates local job opportunities, helping to combat poverty (SDG 1), while food-bearing trees contribute to Zero Hunger (SDG 2).
Pack8's 2030 Sustainability Goals
By 2030, Pack8 aims to eliminate 10,000+ tons of single-use plastic waste through sustainable packaging alternatives. The company is also committed to planting 1 million trees, restoring green cover while offsetting carbon emissions. Another key target is to shift entirely to 100% recycled paper, ensuring responsible and sustainable sourcing of materials.
How You Can Support Project Aranyam
Sustainability is a collective effort, and every individual can contribute. By choosing Pack8's sustainable products, consumers directly support reforestation initiatives. Spreading awareness about Project Aranyam helps drive conversations around the importance of environmental restoration. Engaging in local tree-planting initiatives and adopting eco-friendly habits, such as reducing plastic use and conserving resources, can further amplify the impact.
Conclusion
Pack8's Project Aranyam is setting new standards for corporate responsibility, proving that business growth and environmental impact can go hand in hand. With every tree planted, Pack8 is building a greener tomorrow—(one tree at a time)*. As sustainability becomes a global priority, initiatives like Project Aranyam show that every action counts. Whether by choosing sustainable products, raising awareness, or participating in conservation efforts, we all have a role in shaping a healthier planet.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business Upturn
23 minutes ago
- Business Upturn
BeOne Medicines Showcases Groundbreaking Oncology Pipeline at R&D Day
San Carlos, Calif., United States: BRUKINSA, sonrotoclax, and BTK CDAC data, including combinations, are designed to comprehensively address unmet needs across CLL patient populations Promising new data from pipeline assets in breast, lung, and GI cancer franchises, including CDK4 inhibitor, B7-H4 ADC, and novel PRMT5 inhibitor, will be featured Pipeline is at an exciting inflection point with 20 near-term milestones in the next 18 months In a significant showcase for investors, BeOne Medicines Ltd. (NASDAQ: ONC; HKEX: 06160; SSE: 688235), a global oncology company, will announce major advancements to its industry-leading oncology pipeline during today's investor R&D Day. The event comes at a pivotal moment for the Company, which has more than 40 clinical and commercial stage assets in development, a signal of both scale and ambition. 'At BeOne, our mission is simple yet bold: to create the world's first next-generation oncology company,' said John V. Oyler, Co-Founder, Chairman, and CEO. 'What we will unveil demonstrates our progress towards this goal today, and the promise for tomorrow. From our innovative discovery engine to one of the broadest pipelines in oncology, we are well-positioned to bring transformative medicines to patients worldwide—and to do so with speed, quality, and purpose.' BeOne's integrated, end-to-end R&D model is engineered for efficiency without compromise. The Company's differentiated approach—combining in-house discovery targeting unmet patient needs, parallel early-stage exploration at low incremental cost, and rapid proof-of-concept generation—enables swift progression from bench to clinic. Our in-house manufacturing around the world, including our flagship facility in Hopewell, NJ, means we have a sustainable business model, purpose built with competitive advantages. This rigorous model has fueled a pipeline of more than 40 clinical and commercial-stage assets, making it one of the most productive in the industry. To complement this research engine, BeOne has built a robust global clinical development platform, with more than 170 trials conducted across 40 countries and more than 25,000 patients enrolled to date. In hematologic cancers, the Company's program is driven by its wholly-owned assets including BRUKINSA® (zanubrutinib), a second-generation covalent BTK inhibitor and the backbone of the hematology franchise, sonrotoclax, a potential best-in-class next-generation BCL2 inhibitor, and BGB-16673, a BTK CDAC. New clinical data from CaDAnCe-101 highlight the promise of BGB-16673, a potential first-in-class BTK degrader, for patients with relapsed or refractory B-cell malignancies, including chronic lymphocytic leukemia (CLL). Meanwhile, early data show the combination of sonrotoclax and BRUKINSA has demonstrated compelling efficacy and the potential to offer a best-in-class fixed-duration treatment in CLL, setting the stage for a possible new standard of care. In solid tumors, the Company is advancing multiple targeted modalities beyond its foundational PD-1 inhibitor TEVIMBRA® (tislelizumab-jsgr), including CDK4 inhibitor BGB-43395, which has shown clear pharmacodynamic activity and is expected to enter registration-enabling studies for the treatment of breast cancer within the next six to 12 months. Promising new data for the B7-H4 ADC (BG-C9074) point to a potential first-in-class therapeutic option for patients with B7-H4 expressing tumors, including those without selection criteria. Additionally, early data from the novel PRMT5 inhibitor suggest a favorable safety profile and promising efficacy, supporting its potential for differentiation in the competitive lung cancer field. 'Our R&D team is running at full speed,' said Lai Wang, Ph.D., Global Head of R&D. 'With more than 1,200 scientists and more than 3,700 clinical development and medical affairs colleagues dedicated to pushing the boundaries of oncology, we have built the infrastructure, mindset, and capabilities to deliver sustained innovation. The volume of clinical milestones we anticipate over the next few years is extraordinary, and our agility in moving from idea to execution sets us apart.' Speakers at today's event include BeOne's executive leadership team, senior R&D leaders, and distinguished key opinion leaders, offering a multi-faceted view of the Company's scientific strategy and execution momentum. The live webcast begins at 8:30 a.m. U.S. Eastern Time and is available on the investor relations section of BeOne's website, where an archived version will also be accessible. About BeOne BeOne Medicines is a global oncology company domiciled in Switzerland that is discovering and developing innovative treatments that are more affordable and accessible to cancer patients worldwide. With a portfolio spanning hematology and solid tumors, BeOne is expediting development of its diverse pipeline of novel therapeutics through its internal capabilities and collaborations. With a growing global team of more than 11,000 colleagues spanning six continents, the Company is committed to radically improving access to medicines for far more patients who need them. To learn more about BeOne, please visit and follow us on LinkedIn, X, Facebook and Instagram. Forward-Looking Statements This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 and other federal securities laws, including statements regarding the future success of BeOne's pipeline assets; BeOne's ability to bring transformative medicines to patients worldwide with both speed and quality; the productivity of BeOne's pipeline; the ability of BeOne's assets to provide a new standard of care; the timing for BGB-43395 to enter registration-enabling studies; and BeOne's plans, commitments, aspirations, and goals under the heading 'About BeOne.' Actual results may differ materially from those indicated in the forward-looking statements as a result of various important factors, including BeOne's ability to demonstrate the efficacy and safety of its drug candidates; the clinical results for its drug candidates, which may not support further development or marketing approval; actions of regulatory agencies, which may affect the initiation, timing, and progress of clinical trials and marketing approval; BeOne's ability to achieve commercial success for its marketed medicines and drug candidates, if approved; BeOne's ability to obtain and maintain protection of intellectual property for its medicines and technology; BeOne's reliance on third parties to conduct drug development, manufacturing, commercialization, and other services; BeOne's limited experience in obtaining regulatory approvals and commercializing pharmaceutical products; BeOne's ability to obtain additional funding for operations and to complete the development of its drug candidates and maintain profitability; and those risks more fully discussed in the section entitled 'Risk Factors' in BeOne's most recent quarterly report on Form 10-Q, as well as discussions of potential risks, uncertainties, and other important factors in BeOne's subsequent filings with the U.S. Securities and Exchange Commission. All information in this press release is as of the date of this press release, and BeOne undertakes no duty to update such information unless required by law. To access BeOne media resources, please visit ourNewsroom. View source version on Disclaimer: The above press release comes to you under an arrangement with Business Wire. Business Upturn takes no editorial responsibility for the same. Ahmedabad Plane Crash
Business Upturn
23 minutes ago
- Business Upturn
Camikara: Putting India on the World Rum Map
About Piccadily Agro Industries Limited (PAIL) Piccadily Agro Industries Limited (PAIL) is a publicly listed company on the Bombay Stock Exchange (BSE: PICAGRO). The company operates primarily in two strategic business segments: Distillery and Sugar. Its manufacturing facility is located in Indri, Haryana, covers 168 acres and is equipped with advanced technology for producing a diverse range of products, including Malt, Extra Neutral Alcohol (ENA), Ethanol, and White Crystal Sugar. Piccadily Agro Industries Limited has established itself as a key player in the alcoholic beverages industry, particularly renowned for its expertise in malt spirits. The company boasts a robust portfolio that includes premium expressions of Indri single malt whisky, blended malt whisky brands and Camikara, premium sugarcane juice aged rum. In 2022, Piccadily Agro Industries Limited made a significant mark with the launch of 'Indri' its flagship single malt whisky brand, aimed at catering to discerning consumers who appreciate quality and craftsmanship in spirits. By focusing on premiumization strategies and leveraging its technical capabilities, the company has successfully positioned itself as a leader in the Indian single malt whisky market by becoming the 'fastest growing single malt whisky brand' in 2024. Website: Click here for Media Contact Details Submit your press release Disclaimer: The above press release comes to you under an arrangement with Business Wire. Business Upturn takes no editorial responsibility for the same. Ahmedabad Plane Crash
NBC News
24 minutes ago
- NBC News
California official criticized for appearing to call on gangs to intervene in immigration raids
LOS ANGELES — The vice mayor of a small Southern California city is under fire after appearing to call on street gangs to organize in the face of immigration sweeps by federal agents in and around Los Angeles. In a video post on social media that has since been deleted, Cynthia Gonzalez, vice mayor of Cudahy, referenced two well-known street gangs and questioned why gang members were not protesting or speaking up about the immigration raids. She said ordinary citizens are the ones on the streets protesting the presence of federal agents. "You guys tag everything up, claiming hood, and now that your hood's being invaded by the biggest gang there is, there ain't a peep out of you," Gonzalez said. She referenced "18th Street" and "Florence," two infamous street gangs, and appeared to be speaking directly to their members. She said U.S. Immigration and Customs Enforcement agents are "running amok all up in your streets." "We're out there fighting our turf, protecting our turf, protecting our people and, like, where you at?" she said. The Department of Homeland Security called Gonzalez's comments "despicable" and said the remarks will contribute to rising assaults against federal ICE agents. "She calls for criminal gangs — including the vicious 18th street gang — to commit violence against our brave U.S. Immigration and Customs Enforcement law enforcement," the department said in a post on X that included Gonzalez's video. "Secretary Noem has been clear: If you assault a federal officer, you will be prosecuted to the fullest extent of the law." The Los Angeles Times reported that the police union, formally known as the Los Angeles Police Protective League, called for the vice mayor's resignation and possible prosecution. "What Ms. Gonzalez urged and taunted these specific gangs to do in her social media post puts police officers and other law enforcement professionals at greater risk. Her actions are deplorable and potentially illegal. She should resign and she should be prosecuted if what she called for broke the law," the union said. Gonzalez did not immediately respond to a request for comment. The video comes as President Donald Trump's administration has aggressively stepped up immigration arrests in the Los Angeles area in recent weeks. Agents from ICE, as well as Border Patrol, have been seen arresting and detaining people at their workplaces, and Trump has deployed the National Guard and Marines to protect federal buildings and guard officers making arrests. The remarks appear to break with leading California officials — including Los Angeles Mayor Karen Bass — who have urged residents to peacefully exercise their First Amendment rights. A spokesperson for the U.S. Attorney's Office for the Central District of California, which includes Los Angeles County, declined to comment when asked if Gonzalez was under investigation. According to her biography on the city's website, Gonzalez grew up in nearby Huntington Park, the daughter of immigrant parents. She has two daughters. She received a bachelor's degree from the University of California, Santa Barbara. She later earned two master's degrees in education from the University of California, Los Angeles, where she also earned an educational leadership doctorate, the website said. Gonzalez has worked for the Los Angeles Unified School District as a teacher and school principal in the LA area and is currently the director of pilot schools support and innovation, the biography said. It says Gonzalez "is passionate about creating healthy and safe communities that allow students and families to lead healthy and meaningful lives." The school district said in an emailed statement, "As of June 1, 2025, Cynthia Gonzales has been on a leave of absence. We are aware of the situation and are looking into it in accordance with district policy. However, due to the confidentiality of personnel matters, we are unable to further comment on this." The city of Cudahy said in a statement Tuesday that it was aware of the video. "The comments made by the Vice Mayor reflect her personal views and do not represent the views or official position of the City of Cudahy," the statement read. "The City will not be providing further comment." According to county records, Gonzalez was elected in 2022 with 880 votes. Municipal elections in California are nonpartisan — party labels do not appear on the ballot. Cudahy is a Los Angeles suburb that is home to 22,000 residents, about 10 miles (16.09 kilometers) south of downtown LA. According to the U.S. Census data, 97% of residents are Hispanic or Latino.
